These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7553588)

  • 1. Allelic status of chromosome 1 in neoplasms of the nervous system.
    Bello MJ; Leone PE; Nebreda P; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; García-Miguel P; Queizan A; Hernández-Moneo JL
    Cancer Genet Cytogenet; 1995 Sep; 83(2):160-4. PubMed ID: 7553588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic loss at 1p is associated with tumor progression of meningiomas.
    Bello MJ; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Genes Chromosomes Cancer; 1994 Apr; 9(4):296-8. PubMed ID: 7519053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion mapping of chromosomes 14q and 1p in human neuroblastoma.
    Takayama H; Suzuki T; Mugishima H; Fujisawa T; Ookuni M; Schwab M; Gehring M; Nakamura Y; Sugimura T; Terada M
    Oncogene; 1992 Jun; 7(6):1185-9. PubMed ID: 1594247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution analysis of chromosome arm 1p alterations in meningioma.
    Bello MJ; de Campos JM; Vaquero J; Kusak ME; Sarasa JL; Rey JA
    Cancer Genet Cytogenet; 2000 Jul; 120(1):30-6. PubMed ID: 10913674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion mapping of the short arm of chromosome 1 identifies a common region of deletion distal to D1S496 in human meningiomas.
    Boström J; Mühlbauer A; Reifenberger G
    Acta Neuropathol; 1997 Nov; 94(5):479-85. PubMed ID: 9386781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization.
    Ishino S; Hashimoto N; Fushiki S; Date K; Mori T; Fujimoto M; Nakagawa Y; Ueda S; Abe T; Inazawa J
    Cancer; 1998 Jul; 83(2):360-6. PubMed ID: 9669820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.
    Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M
    Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors.
    Bello MJ; Vaquero J; de Campos JM; Kusak ME; Sarasa JL; Saez-Castresana J; Pestana A; Rey JA
    Int J Cancer; 1994 Apr; 57(2):172-5. PubMed ID: 8157354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.
    Reifenberger J; Reifenberger G; Liu L; James CD; Wechsler W; Collins VP
    Am J Pathol; 1994 Nov; 145(5):1175-90. PubMed ID: 7977648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroblastoma consensus deletion maps to 1p36.1-2.
    Weith A; Martinsson T; Cziepluch C; Brüderlein S; Amler LC; Berthold F; Schwab M
    Genes Chromosomes Cancer; 1989 Nov; 1(2):159-66. PubMed ID: 2487156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci.
    Buckley PG; Jarbo C; Menzel U; Mathiesen T; Scott C; Gregory SG; Langford CF; Dumanski JP
    Cancer Res; 2005 Apr; 65(7):2653-61. PubMed ID: 15805262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
    Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
    Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity.
    Sulman EP; Dumanski JP; White PS; Zhao H; Maris JM; Mathiesen T; Bruder C; Cnaan A; Brodeur GM
    Cancer Res; 1998 Aug; 58(15):3226-30. PubMed ID: 9699646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors.
    Arnoldus EP; Wolters LB; Voormolen JH; van Duinen SG; Raap AK; van der Ploeg M; Peters AC
    J Neurosurg; 1992 Jun; 76(6):997-1003. PubMed ID: 1588436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
    Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors.
    Husemann K; Wolter M; Büschges R; Boström J; Sabel M; Reifenberger G
    J Neuropathol Exp Neurol; 1999 Oct; 58(10):1041-50. PubMed ID: 10515227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of chromosome 22 in human brain tumors determined by combined cytogenetic and molecular genetic approaches.
    Rey JA; Bello MJ; de Campos JM; Vaquero J; Kusak ME; Sarasa JL; Pestaña A
    Cancer Genet Cytogenet; 1993 Mar; 66(1):1-10. PubMed ID: 8467468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of alleles in brain tumours: distribution and correlations with clinical course.
    Diedrich U; Lucius J; Bittermann HJ; Schlösser M; Eckert B; Behnke J; Pabst B
    J Neurol; 1995 Oct; 242(10):707-11. PubMed ID: 8568535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas.
    Lee JY; Finkelstein S; Hamilton RL; Rekha R; King JT; Omalu B
    Neurosurgery; 2004 Nov; 55(5):1163-73. PubMed ID: 15509323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.